Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/6/01 → 5/30/04 |
Funding
- Aventis Pharmaceuticals Products Inc: $2.00
Protocol RP59500V-396 Synercid in the Treatment of Infection Caused by Vacomycin-Resistant Enterococcus Faecium (VREF)
- Greenberg, Richard (PI)
- Pomeroy, Claire (CoI)